Calcified Tissue International

, Volume 81, Issue 6, pp 455–458

Economic Implications of Osteoporosis-Related Femoral Fractures in Saudi Arabian Society

Article

Abstract

Purpose

To assess the prevalence of proximal femoral fractures due to osteopenia and osteoporosis in the eastern province of Saudi Arabia and to estimate the cost of management of osteoporosis-related femoral fractures.

Methods

This is a retrospective study of all patients admitted to the orthopaedic department of the King Fahd Hospital of the University, AlKhobar between January 2001 and December 2006. There were 63 patients admitted to the hospital with osteoporosis-related fractures and 43 sustained proximal femoral fractures. The cost of management of these patients from admission to discharge was analyzed. A verbal survey was carried with all the hospitals in the eastern province to establish the prevalence of osteoporosis-related femoral fractures for a 12 month period.

Results

There were 23 male and 20 female patients with average age of 72.11 years and the hospital stay was for 760 days. The cost of managing these patients was SR2.09 million (US$557,333.00) at the rate of SR48,712 (US$12,989.90) per patient. The survey of all hospitals in the eastern province of Saudi Arabia showed that 984 proximal femoral fractures occurred in a population of 164,121. The estimated cost was SR48 million (US$12.78 million) annually. On a national basis, with a population of 1,461,401 Saudis aged 50 years or more, 8,768 would suffer femoral fractures yearly at a cost of SR4.27 billion (US$1.14 billion).

Conclusion

This study raises serious economic concerns. The annual cost of management of osteoporosis-related proximal femoral fractures in the eastern province of Saudi Arabia is US$12.78 million. As the Saudi Arabian population is aging and the number of elderly patients is bound to increase, with an accompanying increase in fractures, the impact on health care budgets will be tremendous.

Keywords

Economic costs Fracture Femur Osteoporosis 

References

  1. 1.
    Glaser DL, Kaplan FS (1997) Osteoporosis: Definition and clinical presentation. Spine 22:12S–16SPubMedCrossRefGoogle Scholar
  2. 2.
    Sadat-Ali M, Al Elq A (2006) Osteoporosis among male saudi arabs: A pilot study. Ann Saudi Med 26:450–454PubMedGoogle Scholar
  3. 3.
    Ardawi MSM, Maimany AA, Bahksh TM, Nasrat HAN, Milaat WA, Al-Raddadi RM (2005) Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int 16:43–55PubMedCrossRefGoogle Scholar
  4. 4.
    Sadat-Ali M, Al-Habdan I, Al-Mulhim FA, El-Hassan AY (2005) Effect of parity on bone mineral density among postmenopausal Saudi Arabian women. Saudi Med J 26:1588–1590PubMedGoogle Scholar
  5. 5.
    Sadat-Ali M, Al-Habdan I, Al-Mulhim FA, El-Hassan AY (2004) Bone mineral density among postmenopausal Saudi women. Saudi Med J 25:1623–1625PubMedGoogle Scholar
  6. 6.
    Sadat-Ali-M, Al-Habdan I, Marwah S (1996) Bone mineral density measurement of distal radius in Saudi Arabian females. Ann Saudi Med 16:414–416PubMedGoogle Scholar
  7. 7.
    El-Desouki M (2003) Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry. Saudi Med J 24:953–956PubMedGoogle Scholar
  8. 8.
    Pentek M, Horvath C, Bonez I, Falusi Z, Toth E, Sebestyen A, et al. (2007) Epidemiology of osteoporosis-related fractures in Hungary from the nationwide health insurance database 1999–2003. Osteoporosis Int Aug 16, 2007 [Epub ahead of print]Google Scholar
  9. 9.
    Marin F, Gonzalez-Macias J, Moya R, Onrubia C, Cancelo C, Alvarez S, et al. (2006) Fragility non-spinal fractures in a cohort of 5,201 women aged 65 years and older during a 3 year follow-up. Med Clin (Barc) 127:401–404CrossRefGoogle Scholar
  10. 10.
    Al-Nuaim AR, Kremli M, Al-Nuaim M, Sandkgi S (1995) Incidence of proximal femur fracture in an urbanized community in Saudi Arabia. Calcif Tissue Int 56:536–538PubMedCrossRefGoogle Scholar
  11. 11.
    Baddoura R (2001) Incidence of hip fractures in the Lebanese population. East Meiterr Health J 7:725–729Google Scholar
  12. 12.
    Memon A, Pospula WM, Tantawy AY, Abdul-Gaffar S, Suresh A, Al-Rowaih A (1998) Incidence of hip fracture in Kuwait. Int J Epidemiol 27:860–865PubMedCrossRefGoogle Scholar
  13. 13.
    Sadat-Ali M, Gullenpet AH, Al-Mulhim F, Al-Turki H, Al-Shammary H, Al-Elq A, et al. (2007) Osteoporosis-related vertebral fractures: Its prevalence in the Saudi Arabian society. East Mediterr Health J (in press)Google Scholar
  14. 14.
    ICD (1998) International classification of diseases, 9th revision; clinical modification, 6th edn. http://www.cdc.gov/nchs/datawh
  15. 15.
    Sadat-Ali M (2006) Assessment of femoral fractures in eastern province of Saudi Arabia. Personal communicationGoogle Scholar
  16. 16.
  17. 17.
    SPSS (2007) SPSS statistical software package, version 14.0. Chicago, IL: SPSSGoogle Scholar
  18. 18.
    Wicktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadinitropoulos E (2001) Economic implications of hip fracture: Health service use, institutional care and Cost in Canada. Osteoporos Int 12:271–278CrossRefGoogle Scholar
  19. 19.
    Brainsky A, Glick H, Lydick E, Epstein R, Fox KM, Hawkes W, Kashner TM (1997) Dwelling older adults: A prospective study. J Am Geriatr Soc 45:281–287PubMedGoogle Scholar
  20. 20.
    Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. Injury 36:88–91PubMedCrossRefGoogle Scholar
  21. 21.
    Burge RT, Dawson-Hughes B, King AB, Solomon DH, Tosteson A, Wong JB (2005) Incidence and economic burden of osteoporotic fractures in the United States, 2005–2025. http://www.nof.confex.com/nof/2005/techprogram/P400.HTM
  22. 22.
    National Institute for Health and Clinical Excellence (NICE) (2005) Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology appraisal 87. NICE, LondonGoogle Scholar
  23. 23.
    King AB, Saag KG, Burge RT, Pisu M, Goel N (2005) Fracture reduction affects Medicare economics (FRAME): Impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 16:1545–1557PubMedCrossRefGoogle Scholar
  24. 24.
    Diez-Perez A, Puig MJ, Martinez IMT, Guelar GAM, Cucurull CJ, Mellibovsky SL, et al. (1989) Estimate of the costs of osteoporotic fractures of the femur in Spain. Med Clin (Barc) 92:721–723Google Scholar
  25. 25.
    Nguyen ND, Eisman JA, Nguyen TV (2006) Anti-hip fracture efficacy of biophosphonates: A Bayesian analysis of clinical trials. J Bone Miner Res 21:340–349PubMedCrossRefGoogle Scholar
  26. 26.
    Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski J, Spector T, et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468PubMedCrossRefGoogle Scholar
  27. 27.
    Chesnut CC III, et al. (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study. Osteoporos Int 15:792–798PubMedGoogle Scholar
  28. 28.
    Thomas ML, Christopher TW, Russell W, Christopher GM (2005) The current hospital cost of treating hip fractures. Injury 36:88–91CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.College of MedicineKing Faisal UniversityAlKhobarSaudi Arabia
  2. 2.King Fahd Hospital of the UniversityKing Faisal UniversityAlKhobarSaudi Arabia

Personalised recommendations